Inhaled Formoterol Diminishes Insulin-Induced Hypoglycemia in Type 1 Diabetes

OBJECTIVE: Hypoglycemia is one of the major factors limiting implementation of tight glycemic control in patients with type 1 diabetes and is associated with increased morbidity and mortality during intensive insulin treatment. β-2 Adrenergic receptor (AR) agonists have been reported to diminish noc...

Descripción completa

Detalles Bibliográficos
Autores principales: Belfort-DeAguiar, Renata D., Naik, Sarita, Hwang, Janice, Szepietowska, Barbara, Sherwin, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Emerging Technologies and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542274/
https://www.ncbi.nlm.nih.gov/pubmed/26153273
http://dx.doi.org/10.2337/dc14-2472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542274/
https://www.ncbi.nlm.nih.gov/pubmed/26153273
http://dx.doi.org/10.2337/dc14-2472

Ejemplares similares